CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide

Product Details
Customization: Available
CAS No.: 915087-33-1
Formula: C21h16f4n4o2s
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2025

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

Fast Delivery
The supplier can deliver the goods within 15 days
Low MOQ
The MOQ for the supplier's products is 1
QA/QC Inspectors
The supplier has 1 QA and QC inspection staff
Customization from Samples
The supplier provides sample based customization services
to see all verified strength labels (7)
  • CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide
  • CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide
  • CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide
  • CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide
  • CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide
  • CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide
Find Similar Products
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
  • ABOUT US
Overview

Basic Info.

Model NO.
QS-Enzalutamide
EINECS
1592732-453-0
Packaging Material
Negotiable
Storage Method
Normal
Shelf Life
2 Years
Nutrient Composition
Enzalutamide
Resource
Enzalutamide
The content of active substances
99%
Product Name
Enzalutamide
Name
Enzalutamide Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Antineoplastic
Specific
COA
Test Method
HPLC
CAS No
915087-33-1
Mf
C21h16f4n4o2s
MW
464.44
Refractive Index
1.629
Density
1.49
Psa
108.53000
Transport Package
Negotiable
Specification
99%
Trademark
QS
Origin
Shaanxi Xi′an
Production Capacity
500kg/Month

Product Description

CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide
CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide
Product Description
CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer EnzalutamideCAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide
Product Details
CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide
Product Name Enzalutamide
Apperance White Powder
CAS 915087-33-1
MF C21H16F4N4O2S
MW 464.44
Enzalutamide is a nonsteroidal androgen receptor (AR) inhibitor primarily used for the treatment of prostate cancer. Its chemical name is 4- [3- [4-cyano-3- (trifluoromethyl) phenyl] -5,5-dimethyl-4-oxo-2-thioimidazolin-1-yl] -2-fluoro-N-methylbenzamide, and its molecular formula is C21H16F4N4O2S. This drug inhibits the growth and spread of tumor cells by blocking the signaling of androgen receptors. Enzalutamide has high selectivity and potency, and is suitable for patients with castration resistant prostate cancer (CRPC) and metastatic castration sensitive prostate cancer (mCSPC).
Application&Function
CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer EnzalutamideCAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer EnzalutamideEnzalutamide works through a triple mechanism: (1) competitively inhibits the binding of androgens to receptors; (2) Block AR nuclear translocation to prevent it from entering the nucleus; (3) Inhibiting the binding of AR to DNA blocks the expression of genes that promote tumor growth. Clinical studies have shown that enzalutamide can significantly prolong progression free survival (PFS) and overall survival (OS), and reduce the risk of cancer metastasis. This drug is typically used for the treatment of other hormone therapies that have failed, and compared to traditional anti androgen drugs such as bicalutamide, it has lower resistance and longer lasting efficacy.
Specification
CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer EnzalutamideCAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer EnzalutamideCAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer EnzalutamideCAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer EnzalutamideCAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer EnzalutamideCAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide
ABOUT US
CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer EnzalutamideCAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer EnzalutamideCAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer EnzalutamideCAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier